-
-
-
-
-
-
-
Lilly to acquire Orna Therapeutics to advance cell therapies
-
-
-
-
-
-
-
This U.S. biotech stock is Bernstein's Top Pick for 2026
-
-
-
-
-
-
-
Mangoceuticals clarifies GLP-1 weight-management program launch
-
-
-
-
-
-
-
Eli Lilly poised for strong quarter despite profit hit from one-time charge
-
-
-
-
-
-
-
M. Stanley cuts Novo Nordisk to Underweight on ’tough path ahead’, shares slip
-
-
-
-
-
-
-
Lilly raises full-year earnings forecasts on surging demand for weight-loss drug
-
-
-
-
-
-
-
Lilly tender offer for Verve expires with 55.7% of shares tendered
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

